TNF-α was first identified as a potential anti-tumor agent, as it can induce and trigger apoptosis of cancer cells in high doses; however, due to significant toxicities and lack of efficacy, the clinical trials of systemic administration of TNF-α for treating cancer have been disappointing4. This evidence concerns the gene TNF and cancer.